Lannett Co. Inc. (LCI)

4.08
0.21 5.40
NYSE : Health Technology
Prev Close 3.87
Open 3.89
Day Low/High 3.84 / 4.00
52 Wk Low/High 3.35 / 30.35
Volume 134.25K
Avg Volume 1.76M
Exchange NYSE
Shares Outstanding 38.90M
Market Cap 160.67M
EPS 0.80
P/E Ratio 5.36
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABM Downgrades: LCI, PLT Initiations: FVCB Read on to get TheStreet Quant Ratings' detailed report:

LCI LOSS NOTICE: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

LCI LOSS NOTICE: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

NEW YORK, Sept. 13, 2018 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Lannett Company, Inc.

Lifshitz & Miller LLP Announces Investigation Of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. And Zion Oil & Gas, Inc.

Lifshitz & Miller LLP Announces Investigation Of American Express Company, GDS Holdings Limited, Lannett Company, Inc., Mednax, Inc., Menlo Therapeutics Inc., Papa John's International, Inc., Tetraphase Pharmaceuticals, Inc. And Zion Oil & Gas, Inc.

NEW YORK, Sept. 12, 2018 /PRNewswire/ -- American Express Company (AXP) Lifshitz & Miller announces investigation into possible securities laws violations in connection with the FBI probing pricing practices within AXP's foreign-exchange unit.

2 Sagging Stocks Insiders Are Picking Up

2 Sagging Stocks Insiders Are Picking Up

Lannett Co. and Builders FirstSource have seen insiders make purchases at recent low valuations.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Lannett Company, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Lannett Company, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Lannett Company, Inc.

LCI SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lannett Company, Inc. Investors Of Important Deadline In Class Action - LCI

LCI SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lannett Company, Inc. Investors Of Important Deadline In Class Action - LCI

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Lannett Company, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Lannett Company, Inc. Of Class Action Lawsuit And Upcoming Deadline - LCI

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Lannett Company, Inc. Of Class Action Lawsuit And Upcoming Deadline - LCI

NEW YORK, Aug. 31, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lannett Company, Inc.

Lannett Announces Fiscal 2018 Fourth-Quarter And Full-Year Financial Results; Provides Guidance For Fiscal 2019

Lannett Announces Fiscal 2018 Fourth-Quarter And Full-Year Financial Results; Provides Guidance For Fiscal 2019

PHILADELPHIA, Aug. 28, 2018 /PRNewswire/ -- Lannett Company, Inc.

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Lannett Company, Inc. (LCI) And Lead Plaintiff Deadline - October 26, 2018

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Lannett Company, Inc. (LCI) And Lead Plaintiff Deadline - October 26, 2018

NEW YORK, Aug. 28, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Lannett Company, Inc.

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Lannett Company, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Lannett Company, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Lannett Company, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Lannett Company, Inc.

Lannett To Report Fiscal 2018 Fourth-Quarter And Full-Year Financial Results, Host Conference Call On Tuesday, August 28

Lannett To Report Fiscal 2018 Fourth-Quarter And Full-Year Financial Results, Host Conference Call On Tuesday, August 28

PHILADELPHIA, Aug. 22, 2018 /PRNewswire/ -- Lannett Company, Inc.

Interesting LCI Put And Call Options For October 19th

Interesting LCI Put And Call Options For October 19th

Investors in Lannett Co., Inc. saw new options begin trading today, for the October 19th expiration.

Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals

Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals

--Company Announces Preliminary Fiscal 2018 Fourth-Quarter and Full-Year Financial Results; To Host Conference Call Today at 8 a.m. ET--

LCI: Insiders Vs. Shorts

LCI: Insiders Vs. Shorts

The most recent short interest data was recently released for the 07/31/2018 settlement date, and Lannett Co., Inc. is one of the most shorted stocks of the Russell 3000, based on 30.76 "days to cover" versus the median component at 5.19.

Notable Wednesday Option Activity: LCI, SYKE, BXC

Notable Wednesday Option Activity: LCI, SYKE, BXC

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lannett Co., Inc. , where a total of 2,945 contracts have traded so far, representing approximately 294,500 underlying shares.

Lannett Enters Licensing Agreement For Generic Concerta®, Methylphenidate Hydrochloride ER Tablets

Lannett Enters Licensing Agreement For Generic Concerta®, Methylphenidate Hydrochloride ER Tablets

PHILADELPHIA, Aug. 3, 2018 /PRNewswire/ -- Lannett Company, Inc.

Lannett Announces Multiple Product Launches

Lannett Announces Multiple Product Launches

PHILADELPHIA, July 23, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018.

Lannett Enters Oversold Territory

Lannett Enters Oversold Territory

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary

Lannett Announces Restructuring Plan Of Cody Laboratories Subsidiary

PHILADELPHIA, June 29, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced a restructuring and cost reduction plan of its subsidiary, Cody Laboratories (Cody), a developer and manufacturer of pain management active pharmaceutical...

Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated

Lannett Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch Anticipated

PHILADELPHIA, June 1, 2018 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.

July 20th Options Now Available For Lannett (LCI)

Investors in Lannett Co., Inc. saw new options begin trading today, for the July 20th expiration.

Oversold Conditions For Lannett (LCI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of December 21st Options Trading For Lannett (LCI)

Investors in Lannett Co., Inc. saw new options begin trading this week, for the December 21st expiration.

Commit To Buy Lannett At $12.50, Earn 18.4% Annualized Using Options

Commit To Buy Lannett At $12.50, Earn 18.4% Annualized Using Options

Investors considering a purchase of Lannett Co., Inc. stock, but cautious about paying the going market price of $16.55/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Relative Strength Alert For Lannett

Relative Strength Alert For Lannett

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: D+ (Sell)